Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Reproxalap Ophthalmic Solution

Reproxalap Ophthalmic Solution

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Reproxalap Ophthalmic Solution

12 trials tracked of Reproxalap Ophthalmic Solution: 6 in phase 3 or 4 and 2 with published results. The most-cited published study has 10 citations.

12Trials tracked
6Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 6 Phase 2 6
  1. Phase 3 The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. Completed · 10 cited
  2. Phase 3 A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease Completed
  3. Phase 3 ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis Completed
  4. Phase 3 The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease Completed
  5. Phase 3 The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease Completed
  6. Phase 3 The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis Completed
Show 6 more trials
  1. Phase 2 A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber Completed
  2. Phase 2 A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease Completed
  3. Phase 2 A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease Completed
  4. Phase 2 An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber Completed
  5. Phase 2 A Clinical Trial to Assess Subjects With Dry Eye Disease. Completed
  6. Phase 2 A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.